Among two cases with EGFR mutations in the NGS assay, one case had p-stage IVB adenocarcinoma with an L858R point mutation in the LAMP assay, while the other had p-stage IIIA adenocarcinoma with an L858R point mutation only in the NGS assay (Table 3). The gene discussed is EGFR; the disease is adenocarcinoma.